Osteal Therapeutics® is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.The lead product under development, VT-X7, is a drug-device combination product that has the potential to be the first FDA approved antibiotic therapy for local delivery to treat infected joint prosthesis. If approved, VT-X7 has the potential to imp...
Osteal Therapeutics® is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.The lead product under development, VT-X7, is a drug-device combination product that has the potential to be the first FDA approved antibiotic therapy for local delivery to treat infected joint prosthesis. If approved, VT-X7 has the potential to improve outcomes and lower the cost of care for orthopedic surgeons and their patients by providing a faster, more reliable treatment option.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.